Quick Takeaways
- Coastlands Capital LP filed SCHEDULE 13G/A for Eledon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ELDN).
- Disclosed ownership: 5%.
- Date of event: 31 Dec 2025.
Coastlands Capital LP - 31 Dec 2025 SCHEDULE 13G/A Report for Eledon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ELDN)
- Filing Manager
- Coastlands Capital LP
- Reporting Manager
- Coastlands Capital LP
- Symbol
- ELDN
- Shares outstanding
- 78,914,349 shares
- Disclosed Ownership
- 3,937,826 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 16:15:14 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 24 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Coastlands Capital LP disclosed 5% ownership in Eledon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ELDN) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 24 Nov 2025.
- Current filing was accepted on 13 Feb 2026, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Coastlands Capital LP | 5% | 3,937,826 | 0 | 3,937,826 | /s/ Mark Shamia | Chief Operating Officer of the General Partner, Coastlands Capital LLC | |
| Coastlands Capital Partners LP | 5% | 3,937,826 | 0 | 3,937,826 | /s/ Mark Shamia | Chief Operating Officer of the General Partner, Coastlands Capital GP LLC | |
| Coastlands Capital GP LLC | 5% | 3,937,826 | 0 | 3,937,826 | /s/ Mark Shamia | Chief Operating Officer | |
| Coastlands Capital LLC | 5% | 3,937,826 | 0 | 3,937,826 | /s/ Mark Shamia | Chief Operating Officer | |
| Matthew D. Perry | 5% | 3,908,467 | 0 | 3,908,467 | /s/ Matthew D. Perry | Reporting Person |